Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
About Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
10
Genentech, Inc.
1
Clinical Trials at Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
During the past decade, Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)
2015-04-17
2021-03-24
Completed
609
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie"
#1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
According to Clinical.Site data, the most researched conditions in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" are
"Breast Cancer" (5 trials), "Colorectal Cancer" (2 trials), "B-cell Lymphoma" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
Most popular intervention types in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Pertuzumab" (4 trials), "Placebo" (4 trials), "Trastuzumab" (4 trials), "Bevacizumab" (2 trials) and "Capecitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
The vast majority of trials in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
Currently, there are NaN active trials in "Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".